BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,691 | -21.3% | 20,951 | -5.0% | 0.04% | -16.3% |
| Q2 2023 | $1,004,325 | +9.7% | 22,044 | -2.3% | 0.05% | +4.3% |
| Q1 2023 | $915,560 | -38.4% | 22,573 | -22.6% | 0.05% | -28.8% |
| Q4 2022 | $1,486,132 | -8.0% | 29,157 | -2.7% | 0.07% | -16.5% |
| Q3 2022 | $1,614,777 | -17.1% | 29,981 | -1.1% | 0.08% | -7.1% |
| Q2 2022 | $1,947,903 | -18.7% | 30,327 | -1.9% | 0.08% | 0.0% |
| Q1 2022 | $2,395,908 | -51.3% | 30,899 | -46.1% | 0.08% | +26.9% |
| Q4 2021 | $4,916,486 | +3.9% | 57,275 | -2.7% | 0.07% | -2.9% |
| Q3 2021 | $4,733,869 | -3.8% | 58,857 | -3.8% | 0.07% | 0.0% |
| Q2 2021 | $4,922,817 | -20.8% | 61,153 | -17.0% | 0.07% | -25.8% |
| Q1 2021 | $6,214,677 | -1.0% | 73,686 | -5.8% | 0.09% | -1.1% |
| Q4 2020 | $6,279,101 | -3.3% | 78,254 | -3.1% | 0.09% | -16.8% |
| Q3 2020 | $6,492,467 | -10.7% | 80,732 | -4.4% | 0.11% | -12.4% |
| Q2 2020 | $7,272,695 | +3.8% | 84,468 | -2.1% | 0.13% | -13.4% |
| Q1 2020 | $7,008,483 | -3.8% | 86,322 | -0.9% | 0.15% | +23.1% |
| Q4 2019 | $7,284,807 | -4.6% | 87,118 | -0.2% | 0.12% | -6.2% |
| Q3 2019 | $7,635,606 | +25.2% | 87,294 | +17.2% | 0.13% | +25.2% |
| Q2 2019 | $6,100,322 | +7.4% | 74,485 | +6.6% | 0.10% | 0.0% |
| Q1 2019 | $5,680,479 | +16.0% | 69,862 | -6.1% | 0.10% | +5.1% |
| Q4 2018 | $4,896,284 | -15.0% | 74,389 | -0.4% | 0.10% | -4.9% |
| Q3 2018 | $5,760,242 | -99.9% | 74,721 | -2.8% | 0.10% | +12.0% |
| Q2 2018 | $5,676,745,000 | +6.0% | 76,879 | -6.7% | 0.09% | +21.1% |
| Q1 2018 | $5,357,865,000 | +104545.8% | 82,378 | +4.4% | 0.08% | +11.8% |
| Q4 2017 | $5,120,000 | -66.0% | 78,905 | -67.1% | 0.07% | -27.7% |
| Q3 2017 | $15,064,000 | +4.2% | 240,059 | +0.5% | 0.09% | -6.0% |
| Q2 2017 | $14,461,000 | +14.0% | 238,867 | -2.3% | 0.10% | +13.6% |
| Q1 2017 | $12,683,000 | +14.4% | 244,565 | -2.2% | 0.09% | +10.0% |
| Q4 2016 | $11,084,000 | -9.1% | 249,971 | -2.4% | 0.08% | -10.1% |
| Q3 2016 | $12,190,000 | -6.7% | 256,083 | -11.4% | 0.09% | -8.2% |
| Q2 2016 | $13,064,000 | +4.5% | 288,906 | -5.1% | 0.10% | +1.0% |
| Q1 2016 | $12,500,000 | +5.7% | 304,288 | -1.8% | 0.10% | +5.5% |
| Q4 2015 | $11,825,000 | +15.9% | 309,948 | -0.2% | 0.09% | +24.7% |
| Q3 2015 | $10,207,000 | -53.7% | 310,715 | -1.5% | 0.07% | -52.9% |
| Q2 2015 | $22,061,000 | 0.0% | 315,479 | -2.0% | 0.16% | -4.3% |
| Q1 2015 | $22,061,000 | -7.6% | 322,052 | -1.1% | 0.16% | -1.8% |
| Q4 2014 | $23,871,000 | +1.6% | 325,708 | -0.5% | 0.16% | -2.4% |
| Q3 2014 | $23,496,000 | -2.4% | 327,386 | -1.7% | 0.17% | +1.2% |
| Q2 2014 | $24,083,000 | -6.2% | 333,099 | -4.5% | 0.17% | -6.2% |
| Q1 2014 | $25,667,000 | +4.3% | 348,831 | -1.4% | 0.18% | +2.9% |
| Q4 2013 | $24,603,000 | +5.0% | 353,747 | -0.8% | 0.17% | -3.4% |
| Q3 2013 | $23,424,000 | -5.8% | 356,591 | -0.7% | 0.18% | -9.6% |
| Q2 2013 | $24,864,000 | – | 358,949 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |